Racke MK - Search Results

1

Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.

Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK. Perrin PJ, et al. Among authors: racke mk. J Immunol. 1995 Feb 1;154(3):1481-90. J Immunol. 1995. PMID: 7529805

2

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.

Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE. Racke MK, et al. J Immunol. 1995 Jan 1;154(1):450-8. J Immunol. 1995. PMID: 7527821

3

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Racke MK, Scott DE, Quigley L, Gray GS, Abe R, June CH, Perrin PJ. Racke MK, et al. J Clin Invest. 1995 Nov;96(5):2195-203. doi: 10.1172/JCI118274. J Clin Invest. 1995. PMID: 7593605 Free PMC article.

4

Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome.

Racke MK, Quigley L, Cannella B, Raine CS, McFarlin DE, Scott DE. Racke MK, et al. J Immunol. 1994 Feb 15;152(4):2051-9. J Immunol. 1994. PMID: 8120406

5

Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.

Perrin PJ, Scott D, Davis TA, Gray GS, Doggett MJ, Abe R, June CH, Racke MK. Perrin PJ, et al. Among authors: racke mk. J Neuroimmunol. 1996 Mar;65(1):31-9. doi: 10.1016/0165-5728(95)00172-7. J Neuroimmunol. 1996. PMID: 8642061

6

CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.

Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK. Perrin PJ, et al. Among authors: racke mk. J Immunol. 1996 Aug 15;157(4):1333-6. J Immunol. 1996. PMID: 8759711

7

B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.

Perrin PJ, Scott D, June CH, Racke MK. Perrin PJ, et al. Among authors: racke mk. Immunol Res. 1995;14(3):189-99. doi: 10.1007/BF02918216. Immunol Res. 1995. PMID: 8778209 Review.

8

Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis.

Perrin PJ, June CH, Maldonado JH, Ratts RB, Racke MK. Perrin PJ, et al. Among authors: racke mk. J Immunol. 1999 Aug 1;163(3):1704-10. J Immunol. 1999. PMID: 10415078

9

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Racke MK, et al. J Immunol. 1991 May 1;146(9):3012-7. J Immunol. 1991. PMID: 1707929

10

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK. Lovett-Racke AE, et al. Among authors: racke mk. J Clin Invest. 1998 Feb 15;101(4):725-30. doi: 10.1172/JCI1528. J Clin Invest. 1998. PMID: 9466965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters